Successful discontinuation rate · participants with long‐term antidepressants for depressive or anxiety disorders
1 finding from 1 review
Relapse · participants with long‐term antidepressants for depressive or anxiety disorders
1 finding from 1 review
Withdrawal symptoms · participants with long‐term antidepressants for depressive or anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · participants with long‐term antidepressants for depressive or anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depressive symptoms · participants with long‐term antidepressants for depressive or anxiety disorders
1 finding from 1 review
Anxiety · participants with long‐term antidepressants for depressive or anxiety disorders
1 finding from 1 review
Quality of life · participants with long‐term antidepressants for depressive or anxiety disorders
1 finding from 1 review
Social and occupational functioning · participants with long‐term antidepressants for depressive or anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of depression ‐ long‐term: >12 months · adults with long‐term physical conditions (18 years or older)
1 finding from 1 review
Incidence of depression ‐ long term: > 12 months · adults with long‐term physical conditions (18 years or older)
1 finding from 1 review
Status of long‐term physical condition short‐term · anxiety and depression in children and adolescents with long‐term physical conditions
1 finding from 1 review
Status of long‐term physical condition (postintervention) · children and adolescents, aged 10 to 18 years, with long‐term physical conditions
1 finding from 1 review
Repetition of SH at post‐intervention · self‐harm in adults
Comparison 12.8: Long‐term therapy showed no clear difference in repetition of SH at post‐intervention compared with TAU or another comparator (low certainty).
1 finding from 1 review
Repetition of SH at post‐intervention · self‐harm in adults
Comparison 2.4: DBT prolonged exposure protocol showed no clear difference in repetition of SH at post‐intervention compared with TAU or another comparator (moderate certainty).
1 finding from 1 review
Adverse effects: 2. Extrapyramidal ‐ akathisia · participants of any age with a primary diagnosis of major depressive disorder
Brexpiprazole probably leads to higher adverse effects: akathisia (followed up until the end of the longest compared with antidepressive agents (moderate certainty).
1 finding from 1 review
Weight gain · participants of any age with a primary diagnosis of major depressive disorder
Brexpiprazole probably leads to higher adverse effects: weight gain (followed up until the end of the longest compared with antidepressive agents (moderate certainty).
1 finding from 1 review
Withdrawal from treatment due to any reason, 6‐12 months after intervention initiation (long term) · bipolar disorder
Lamotrigine showed no clear difference in withdrawal from treatment due to any reason, 6‐12 months after… compared with lithium (moderate certainty).
1 finding from 1 review
Any reported adverse effects 6‐12 months after initiating the intervention (long term) · bipolar disorder
Lamotrigine probably leads to lower any reported adverse effects 6‐12 months after initiating the… compared with lithium (moderate certainty).
1 finding from 1 review
Withdrawal from treatment due to any reason, 6‐12 months after intervention initiation (long term) · bipolar disorder
Lamotrigine probably leads to lower withdrawal from treatment due to any reason, 6‐12 months after… compared with placebo (moderate certainty).
1 finding from 1 review
Any reported adverse effects 6‐12 months after initiating the intervention (long term) · bipolar disorder
Lamotrigine showed no clear difference in any reported adverse effects 6‐12 months after initiating the… compared with placebo (moderate certainty).
1 finding from 1 review